A Closer Look At Tonix’s Pending PTSD Data – Seeking Alpha
A Closer Look At Tonix’s Pending PTSD Data Seeking Alpha Tonix Pharmaceuticals is developing TNX-102 SL for the treatment of posttraumatic stress disorder (PTSD) currently in a Phase 2 trial of a population with military-related PTSD. There are currently very few effective treatments for PTSD, with only two … |